10 Results for "

hCPT

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "hCPT" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-N0095
CAS No.: 19685-09-7
Synonyms: 10-hCPT; 10-Hydroxycamptothecin
(S)-10-Hydroxycamptothecin (10-HCPT;10-Hydroxycamptothecin) is a DNA topoisomerase I inhibitor of isolated from the Chinese plant Camptotheca accuminata. (S)-10-Hydroxycamptothecin exhibits a remarkable apoptosis-inducing effect. (S)-10-Hydroxycamptothecin has the potential for hepatoma, gastric carcinoma, colon cancer and leukaemia treatment .
loading...
    loading...
Cat. No.: HY-N0275
CAS No.: 64439-81-2
Synonyms: (±)-10-hCPT
(±)-10-Hydroxycamptothecin is an indole alkaloid that inhibits the activity of topoisomerase I and has a broad spectrum of anticancer activity.
loading...
    loading...
Cat. No.: HY-13622
CAS No.: 220997-99-9
Synonyms: BN 80927
Target:  

Topoisomerase

Research Areas:  

Cancer

Elomotecan hydrochloride (BN 80927) is an orally active, potent inhibitor of topoisomerases I and II and a homocamptothecin (hCPT) analogue. Elomotecan hydrochloride possesses a dual inhibitory mechanism: it acts as a topoisomerase I poison by stabilizing the DNA-enzyme complex while simultaneously serving as a catalytic inhibitor of topoisomerase II. Elomotecan hydrochloride is used in research concerning various advanced and multidrug-resistant (MDR) solid tumors (such as prostate, colon, and breast cancers) .
loading...
    loading...
Cat. No.: HY-13622A
CAS No.: 220998-10-7
Synonyms: BN 80927 free base
Target:  

Topoisomerase

Research Areas:  

Cancer

Elomotecan (BN 80927 free base) is an orally active, potent inhibitor of topoisomerases I and II and a homocamptothecin (hCPT) analogue. Elomotecan possesses a dual inhibitory mechanism: it acts as a topoisomerase I poison by stabilizing the DNA-enzyme complex while simultaneously serving as a catalytic inhibitor of topoisomerase II. Elomotecan is used in research concerning various advanced and multidrug-resistant (MDR) solid tumors (such as prostate, colon, and breast cancers) .
loading...
    loading...
Cat. No.: HY-170842
Target:  

Apoptosis

Research Areas:  

Cancer

TDK-HCPT is a small-molecule conjugate that links glutathione-sensitive thiamine disulfide to the chemotherapy drug 10-Hydroxycamptothecin (HY-N0095) via a thioketal bond. TDK-HCPT can target tumor cells and prolong the retention of chemotherapy agents within tumor cells. TDK-HCPT can inhibit tumor growth, induce apoptosis of tumor cells, and has anti-tumor activity .
loading...
    loading...
Cat. No.: HY-N0095S
CAS No.: 1330277-66-1
Synonyms: 10-hCPT-d5; 10-Hydroxycamptothecin-d5
(S)-10-Hydroxycamptothecin-d5 (10-HCPT-d5) is the deuterium labeled (S)-10-Hydroxycamptothecin. (S)-10-Hydroxycamptothecin (10-HCPT) is a DNA topoisomerase I inhibitor. (S)-10-Hydroxycamptothecin exhibits a remarkable apoptosis-inducing effect. (S)-10-Hydroxycamptothecin has the potential for hepatoma, gastric carcinoma, colon cancer and leukaemia research .
loading...
    loading...
Cat. No.: HY-N0095R
CAS No.: 19685-09-7
Synonyms: 10-hCPT (Standard); 10-Hydroxycamptothecin (Standard)
(S)-10-Hydroxycamptothecin (Standard) is the analytical standard of (S)-10-Hydroxycamptothecin. This product is intended for research and analytical applications. (S)-10-Hydroxycamptothecin (10-HCPT;10-Hydroxycamptothecin) is a DNA topoisomerase I inhibitor of isolated from the Chinese plant Camptotheca accuminata. (S)-10-Hydroxycamptothecin exhibits a remarkable apoptosis-inducing effect. (S)-10-Hydroxycamptothecin has the potential for hepatoma, gastric carcinoma, colon cancer and leukaemia treatment .
loading...
    loading...
Cat. No.: HY-N0275R
CAS No.: 64439-81-2
Synonyms: (±)-10-hCPT (Standard)
(±)-10-Hydroxycamptothecin (Standard) is the analytical standard of (±)-10-Hydroxycamptothecin. This product is intended for research and analytical applications. (±)-10-Hydroxycamptothecin is an indole alkaloid that inhibits the activity of topoisomerase I and has a broad spectrum of anticancer activity.
loading...
    loading...
Cat. No.: HY-181694
Research Areas:  

Cancer

SeSA-HCPT is an orally active dual-target inhibitor integrating Topo I and HDAC inhibition. SeSA-HCPT induces potent DNA damage, apoptosis, S-phase arrest in prostate cancer cells. SeSA-HCPT inhibits cancer cells proliferation and migration. SeSA-HCPT impairs homologous recombination by suppressing KIF4A-RAD51 signaling. SeSA-HCPT markedly inhibits CRPC tumor growth with minimal systemic toxicity .
loading...
    loading...
Cat. No.: HY-13622B
Synonyms: BN 80927 TFA
Target:  

Topoisomerase

Research Areas:  

Cancer

Elomotecan TFA (BN 80927 TFA) is an orally active, potent inhibitor of topoisomerases I and II and a homocamptothecin (hCPT) analogue. Elomotecan TFA possesses a dual inhibitory mechanism: it acts as a topoisomerase I poison by stabilizing the DNA-enzyme complex while simultaneously serving as a catalytic inhibitor of topoisomerase II. Elomotecan TFA is used in research concerning various advanced and multidrug-resistant (MDR) solid tumors (such as prostate, colon, and breast cancers) .
loading...
    loading...